Analysis of global skin cancer epidemiology in 2022 and correlation with dermatologist density
- PMID: 40736168
- PMCID: PMC13014440
- DOI: 10.1111/jdv.20883
Analysis of global skin cancer epidemiology in 2022 and correlation with dermatologist density
Keywords: basal cell carcinoma; dermatologists; melanoma; non melanoma skin cancer; skin cancer; squamous cell carcinoma.
Conflict of interest statement
Dr Kerob and Mr Salah are employees of La Roche‐Posay. Pr Ezzedine has served as a consultant for La Roche‐Posay, L'Oréal, Incyte, MSD, BMS, AbbVie, Pfizer and Pierre Fabre. Pr Passeron has served as a consultant for La Roche‐Posay, L'Oréal, SVR, Symrise, Isis Pharma, Bioderma, Beiersdorf, ISDIN, Pierre Fabre and Hyphen. Dr Khurana and Mr Balan are employees of FutureBridge and have served as consultants for La Roche‐Posay.
Figures
References
-
- International Agency for Research on Cancer . Global cancer observatory: cancer today. Lyon: IARC; 2024. [accessed 8 Feb 2024]. Available from: https://gco.iarc.fr/today
-
- U.S. Cancer Statistics Working Group . 2024 U.S. Cancer statistics data visualizations tool. Atlanta: Centers for Disease Control and Prevention; [accessed 8 Feb 2024]. Available from: https://www.cdc.gov/cancer/dataviz
-
- Segi M. Cancer mortality for selected sites in 24 countries (1950–57). Sendai: Tohoku University of Medicine; 1960.
-
- L'Oreal . Global dermatologist density survey [unpublished data]. 2024.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
